Compare DSWL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | ELUT |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Macau | United States |
| Employees | 854 | N/A |
| Industry | Plastic Products | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 42.5M |
| IPO Year | 2000 | 2020 |
| Metric | DSWL | ELUT |
|---|---|---|
| Price | $3.04 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 93.2K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.84 | $0.50 |
| 52 Week High | $4.06 | $1.39 |
| Indicator | DSWL | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 47.55 |
| Support Level | $2.96 | $0.75 |
| Resistance Level | $3.32 | $0.84 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 29.41 | 65.35 |
Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.